BM4SIT is a health project supported by the European Union
Latest News

BM4SIT project presentations at the SIICA Congress 2017 in Bari, Italy

 

  

   

 

May 28th-31st, 2017
BM4SIT at the SIICA congress

The BM4SIT consortium has organized scientific presentations that took place at the congress of the Italian society of immunology, clinical immunology and allergology (SIICA) 2017 in Bari, Italy from 28th to 31th of May 2017.

BM4SIT Consortium Meeting 2016 in Amsterdam, the Netherlands

  

   

Meeting participants (from left to right):
1st row:  E.
C. de Jong, AMC; D. van Egmond, AMC; E. de Groot, AMC; A. Neubauer, Biomay; V. Ranta-Panula, UTU
2nd row: O. Pfaar, Allergy Center Wiesbaden; F. Stolz, Biomay; C. Bindslev-Jensen, OUH; W. Fokkens, AMC; R. van Ree, AMC; L. Zuidmeer-Jongejan, AMC; C.M. van Drunen, AMC; M. Wallner, PLUS; L. van Rijt, AMC
Not on picture: F. Ferreira, PLUS; K. Lemmens, Clinical Trial Center Maastricht  

Foto: © L. Aglas, PLUS

November 21st-22nd, 2016
BM4SIT Consortium Meeting

The BM4SIT consortium meeting that took place in Amsterdam, the Netherlands from the 21st to 22nd of November 2016 was very successful. Representatives from almost all project partners were present, including the Academic Medical Center Amsterdam (AMC), the University of Salzburg (PLUS), the University of Turku (UTU), the Allergy Center Wiesbaden, Biomay AG and the Odense University Hospital (OUH).


The following topics were discussed during the meeting:

  • Drug development and production
  • Quality control of drug substance
  • Aptamers
  • Outcome of first clinical trial
  • Immunological testing in vitamin D3 trial
  • Protocol of second clinical trial defined
  • Results from toxicity study 

 

 

The project BM4SIT was presented at the EAACI 2016 Annual Congress in Vienna, Austria

 

June 11-15th, 2016
BM4SIT Poster Presentations

The "EAACI 2016 Annual Congress" took place in the beautiful city of Vienna, Austria. It was an amazing event for all participants. At this point, thanks to the organizing committee for realizing this special event.

Lorenz Aglas from the University of Salzburg (PLUS) presented his results during a poster discussion session. The title of his presentation was "Development of an aptamer-based tool for quality control of a birch pollen immunotherapy vaccine". He also presented a second poster entitled, "Immunologic evaluation of the hypoallergenic birch pollen AIT vaccine candidate BM4 during toxicity testing". Both presentations were very interesting and gave the scientific community the chance to inform themselves about the project BM4SIT.

Foto: © L. Aglas, PLUS

 

 

Presentation of αBM4-specific Aptamers at the "3rd Oxford Symposium on Aptamers" in Oxford, United Kingdom

April 4-5th, 2016
BM4SIT Poster Presentation

The "3rd Oxford Symposium on Aptamers", that took place in Oxford, United Kingdom, was a success for all participants. At this point, thanks to the organizing committee for realizing such an informative event on aptamers.

Lorenz Aglas from the University of Salzburg (PLUS) presented his results on a poster entitled "Development of an enzyme-linked apta-sorbent assay (ELASA) for the quality control of a birch pollen immunotherapy vaccine", which was very successful.

Foto and Poster: © L. Aglas, PLUS

 

 

The BM4SIT Homepage is ONLINE

 

July 27th, 2015
BM4SIT Homepage: Online

Today, the 27th of July 2015, is the official launching of the BM4SIT homepage.

 

 

BM4SIT Meeting Vienna 2015

Meeting participants (from left to right):
1st row: F. Stolz, Biomay; F. Ferreira, PLUS; I. Terreehorst, AMC; R. van Ree, AMC; E.
C. de Jong, AMC; L. Knaepen, CTCM; A. Neubauer, Biomay; C. de Bont, CTCM
2nd row: L. Aglas, PLUS; O. Pfaar, Allergy Center Wiesbaden; C.M. van Drunen, AMC; L. Zuidmeer-Jongejan, AMC; C. Bindslev-Jensen, OUH; M. Jutel, ALL-MED
Foto: © M. Wallner, PLUS

May 18rd-19th, 2015
BM4SIT Meeting: Vienna

The BM4SIT meeting 2015 took place at Biomay in Vienna. After a summary of all changes in the project and the proposed actions, presentations on the recent progress on the BM4/ vitamin D3 program were presented.
The consortium discussed the scientific progress of the project, the protocols of the clinical trials, and the dissemination strategy. Furthermore, to-dos and milestones for the next project period were reviewed. 

Kickoff Meeting Amsterdam

February 3rd-4th, 2014
Kickoff Meeting: Amsterdam

BM4SIT was officially launched on February 3rd at the AMC in Amsterdam. After presentations on recent progress on the BM4/ vitamin D3 program, the consortium decided on to-dos and milestones for the first project period. 

 

 


 

Links to: